{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:22:50Z","timestamp":1788870170346,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.cellimm.2015.01.019","type":"journal-article","created":{"date-parts":[[2015,2,14]],"date-time":"2015-02-14T10:17:44Z","timestamp":1423909064000},"page":"50-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Modulation of human gamma\/delta T-cell activation and phenotype by histone deacetylase inhibitors"],"prefix":"10.1016","volume":"296","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8119-0293","authenticated-orcid":false,"given":"Jaydeep","family":"Bhat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Heinrich","family":"Oberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Kabelitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2015.01.019_b0005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-065X.1991.tb00591.x","article-title":"Biology of the human \u03b3\u03b4 T-cell receptor","volume":"120","author":"Porcelli","year":"1991","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cellimm.2015.01.019_b0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/375155a0","article-title":"Natural and synthetic non-peptide antigens recognized by human \u03b3\u03b4 T cells","volume":"375","author":"Tanaka","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2015.01.019_b0015","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood.V96.2.384.013k07_384_392","article-title":"Stimulation of \u03b3\u03b4 T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma","volume":"96","author":"Kunzmann","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2015.01.019_b0020","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.4049\/jimmunol.167.12.6773","article-title":"Essential contribution of germline-encoded lysine residues in Jgamma1.2 segment to the recognition of nonpeptide antigens by human gammadelta T cells","volume":"167","author":"Miyagawa","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2015.01.019_b0025","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1182\/blood-2012-05-430470","article-title":"Key implication of CD277\/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human \u03b3\u03b4 T-cell subset","volume":"120","author":"Harly","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2015.01.019_b0030","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/ni.2665","article-title":"Butyrophilin 3A1 binds phosphorylated antigens and stimulates human \u03b3\u03b4 T cells","volume":"14","author":"Vavassori","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2015.01.019_b0035","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3389\/fimmu.2014.00679","article-title":"Phosphoantigen presentation to TCR cells, a conundrum getting less gray zones","volume":"5","author":"de Libero","year":"2015","journal-title":"Front Immunol."},{"key":"10.1016\/j.cellimm.2015.01.019_b0040","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.immuni.2014.03.003","article-title":"The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human V\u03b39V\u03b42 T cells","volume":"40","author":"Sandstrom","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2015.01.019_b0045","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3389\/fimmu.2014.00688","article-title":"Sensing of pyrophosphate metabolites by V\u03b39V\u03b42 T cells","volume":"5","author":"Gu","year":"2015","journal-title":"Front Immunol."},{"key":"10.1016\/j.cellimm.2015.01.019_b0050","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2141.2008.07435.x","article-title":"Peripheral blood monocytes are responsible for \u03b3\u03b4 T cell activation induced by zoledronic acid through accumulation of IPP\/DMAPP","volume":"144","author":"Roelofs","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cellimm.2015.01.019_b0055","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-3083.2012.02727.x","article-title":"The multifunctionality of human V\u03b39V\u03b42 \u03b3\u03b4 T cells: clonal plasticity or distinct subsets?","volume":"76","author":"Kabelitz","year":"2012","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.cellimm.2015.01.019_b0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/47412","article-title":"The language of covalent histone modifications","volume":"403","author":"Strahl","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2015.01.019_b0065","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/30613","article-title":"Methylation meets acetylation","volume":"393","author":"Bestor","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2015.01.019_b0070","doi-asserted-by":"crossref","first-page":"27586","DOI":"10.1074\/jbc.M303740200","article-title":"Valproate induces replication-independent active DNA demethylation","volume":"278","author":"Detich","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2015.01.019_b0075","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2015.01.019_b0080","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1158\/0008-5472.CAN-03-0799","article-title":"Histone deacetylase is a target of valproic acid-mediated cellular differentiation","volume":"64","author":"Gurvich","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2015.01.019_b0085","first-page":"23","article-title":"Valproate in psychiatric disorders: literature review and clinical guidelines","volume":"50","author":"McElroy","year":"1989","journal-title":"J. Clin. Psych."},{"key":"10.1016\/j.cellimm.2015.01.019_b0090","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/479364","article-title":"Molecular and therapeutic potential and toxicity of valproic acid","author":"Chateauvieux","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.cellimm.2015.01.019_b0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrd1930","article-title":"Epigenetic therapy of cancer: past, present and future","volume":"5","author":"Yoo","year":"2006","journal-title":"Nat. Rev. Drug Disc."},{"key":"10.1016\/j.cellimm.2015.01.019_b0100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1158\/0008-5472.CAN-06-3069","article-title":"Perspectives of T cells in tumor immunology","volume":"67","author":"Kabelitz","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2015.01.019_b0105","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.4049\/jimmunol.173.8.5077","article-title":"Caspase inhibition blocks human T cell proliferation by suppressing appropriate regulation of IL-2, CD25, and cell cycle-associated proteins","volume":"173","author":"Falk","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2015.01.019_b0110","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.4049\/jimmunol.141.11.3868","article-title":"Human T cell activation with phytohemagglutinin. The function of IL-6 as an accessory signal","volume":"141","author":"Ceuppens","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2015.01.019_b0115","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2249.2003.02203.x","article-title":"Bacterial superantigens","volume":"133","author":"Proft","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cellimm.2015.01.019_b0120","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.4049\/jimmunol.172.10.6136","article-title":"IL-2 secretion by CD4+T cells in vivo is rapid, transient, and influenced by TCR-specific competition","volume":"172","author":"Sojka","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2015.01.019_b0125","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/eji.1830270422","article-title":"Comparative analysis of alpha beta and gamma delta T cell activation by Mycobacterium tuberculosis and isopentenyl pyrophosphate","volume":"27","author":"Wesch","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cellimm.2015.01.019_b0130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00019052-200304000-00014","article-title":"New CNS-active drugs which are second-generation valproic acid: can they lead to the development of a magic bullet?","volume":"16","author":"Isoherranen","year":"2003","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.cellimm.2015.01.019_b0135","doi-asserted-by":"crossref","first-page":"119","DOI":"10.7150\/ijbs.7823","article-title":"\u03b3\u03b4 T cells and their potential for immunotherapy","volume":"10","author":"Wu","year":"2014","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cellimm.2015.01.019_b0140","doi-asserted-by":"crossref","first-page":"e27572","DOI":"10.4161\/onci.27572","article-title":"\u03b3\u03b4 T cells for cancer immunotherapy A systematic review of clinical trials","volume":"3","author":"Fisher","year":"2014","journal-title":"OncoImmunology"},{"key":"10.1016\/j.cellimm.2015.01.019_b0145","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1182\/blood.V98.5.1616","article-title":"V\u03b32V\u03b42 T-cell receptor-mediated recognition of aminobisphosphonates","volume":"98","author":"Das","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2015.01.019_b0150","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-3083.2007.01963.x","article-title":"Lysis of a broad range of epithelial tumour cells by human\u03b3\u03b4T cells: Involvement of NKG2D ligands and T-cell receptor-versus NKG2D-dependent recognition","volume":"66","author":"Wrobel","year":"2007","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.cellimm.2015.01.019_b0155","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1158\/0008-5472.CAN-04-4252","article-title":"Natural Killer cell\u2013mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate","volume":"65","author":"Armeanu","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2015.01.019_b0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.canlet.2010.04.029","article-title":"HDAC inhibitors with different gene regulation activities depend on the mitochondrial pathway for the sensitization of leukemic T cells to TRAIL-induced apoptosis","volume":"297","author":"Morales","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellimm.2015.01.019_b0165","doi-asserted-by":"crossref","first-page":"28656","DOI":"10.1074\/jbc.M112.356584","article-title":"The antiepileptic drug valproic acid restores T cell homeostasis and ameliorates pathogenesis of experimental autoimmune encephalomyelitis","volume":"287","author":"Lv","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2015.01.019_b0170","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1074\/jbc.M113.517599","article-title":"Histone deacetylase inhibitors modulate interleukin 6-dependent CD4+ T cell polarization in vitro and in vivo","volume":"289","author":"Glauben","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2015.01.019_b0175","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1126\/science.1110267","article-title":"Professional antigen-presentation function by human \u03b3\u03b4 T Cells","volume":"309","author":"Brandes","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2015.01.019_b0180","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.4049\/jimmunol.1102654","article-title":"Human \u03b3\u03b4 T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells","volume":"188","author":"Himoudi","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2015.01.019_b0185","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00018-013-1467-1","article-title":"Phenotype and regulation of immunosuppressive V\u03b42-expressing \u03b3\u03b4 T cells","volume":"71","author":"Peters","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cellimm.2015.01.019_b0190","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4161\/cc.7.4.5405","article-title":"Effect of valproic acid on radiation-induced DNA damage in euchromatic and heterochromatic compartments","volume":"7","author":"Harikrishnan","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.cellimm.2015.01.019_b0195","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.molonc.2014.05.001","article-title":"Histone deacetylase inhibitor-mediated cell death is distinct from its global effect on chromatin","volume":"8","author":"Luchenko","year":"2014","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.cellimm.2015.01.019_b0200","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4155\/cli.13.23","article-title":"Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer","volume":"3","author":"Goyal","year":"2013","journal-title":"Clin. Invest."},{"key":"10.1016\/j.cellimm.2015.01.019_b0205","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1182\/blood-2012-10-461988","article-title":"A dual role for HDAC1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance","volume":"121","author":"Santoro","year":"2013","journal-title":"Blood"}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874915000271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874915000271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:54:35Z","timestamp":1757804075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874915000271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0008874915000271"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2015.01.019","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of human gamma\/delta T-cell activation and phenotype by histone deacetylase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2015.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}